10月19日：日本大寿命人寿旗下单位已提出收购澳大利亚投资管理公司挑战者（Challenger）其尚未持有的超过79%股份的意向性要约，挑战者公司周一表示。
Oct 19 : A unit of Japan's Daiichi Life has made an indicative proposal to buy more than 79 per cent of shares in Australian investment manager Challenger it does not already own, Challenger said on Monday.
在该要约中，日本保险公司每股报价11.80澳元，使挑战者公司的估值达到79.4亿澳元（约55.3亿美元）。该要约较该股票周五收盘价溢价19.8%。
Under the proposal, the Japanese insurer is offering A$11.80 apiece, valuing Challenger at A$7.94 billion ($5.53 billion). The offer represents a premium of 19.8 per cent over the stock's closing price on Friday.
根据LSEG的数据，该单位TAL Daiichi Life Australia Pty目前持有挑战者公司20.36%的股份。大寿命人寿通过其子公司，曾于2025年4月从MS&AD保险集团控股公司初步收购了挑战者公司15.1%的少数股权。
The unit, TAL Daiichi Life Australia Pty, holds 20.36 per cent of the Australian investment manager, according to LSEG. Daiichi Life, through its unit, had initially acquired a 15.1 per cent minority stake in Challenger from MS&AD Insurance Group Holdings in April 2025.
挑战者公司周一表示，该收购要约需满足多项条件，包括顺利完成尽职调查。
The takeover proposal is subject to a number of conditions including satisfactory completion of due diligence, Challenger said on Monday.
“挑战者公司董事会正在考虑该意向性要约，”澳大利亚公司补充道。大寿命人寿未能立即回应路透社在非工作时间的置评请求。
"The Board of Challenger is considering the indicative offer," the Australian firm added. Daiichi Life did not respond immediately to a Reuters request for comment outside business hours.
另据挑战者公司报告，其财政2027年第一季度的管理资产规模较去年同期增长5%，达到319亿美元，公司称这是由于国内外年金业务销售势头强劲所致。
Separately, Challenger reported a 5 per cent rise in its assets under management to $31.9 billion for the first quarter of fiscal 2027, citing strong sales momentum across both domestic and offshore annuities.